oxidronic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| calcium metabolism regulator, pharmaceutical aid | 3409 | 15468-10-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Bone scan abnormal | 101.63 | 78.56 | 10 | 47 | 208 | 79744123 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 1.15 | acidic |
| pKa2 | 5.22 | acidic |
| pKa3 | 6.21 | acidic |
| pKa4 | 10.27 | acidic |
| pKa5 | 12.13 | acidic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D05296 | KEGG_DRUG |
| 14255-61-9 | SECONDARY_CAS_RN |
| C1337343 | UMLSCUI |
| CHEBI:134844 | CHEBI |
| CHEMBL1615775 | ChEMBL_ID |
| DB14159 | DRUGBANK_ID |
| 27304 | PUBCHEM_CID |
| 4727 | INN_ID |
| C029285 | MESH_SUPPLEMENTAL_RECORD_UI |
| 71MR4V32TI | UNII |
| 1306067 | RXNORM |
| 009835 | NDDF |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Technescan HDP | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69945-091 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3.15 mg | INTRAVENOUS | NDA | 16 sections |
| Technescan HDP | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69945-091 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 3.15 mg | INTRAVENOUS | NDA | 16 sections |